You are here

  • Home
  • Archive
  • Volume 9, Issue 8
  • Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

Article Text

Article menu

Download PDFPDF

XML
Correction
Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

https://doi.org/10.1136/jitc-2019-000218corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Martens AWJ, Janssen SR, Derks IAM, et al. CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells. J Immunother Cancer 2020;8:e000218. doi: 10.1136/jitc-2019-000218

    This paper has been updated since first published to update Figure 5I. One patient was removed from the figure since the patient originally labeled as chronic lymphocytic leukemia, has been recently re-diagnosed as indolent CD5 +mantle cell lymphoma.